• Caspase 3/7 Drive Cytoprotective Autophagy in Breast Cancer

  2026-04-25

  This study uncovers a conserved, non-apoptotic role for caspase 3 and caspase 7 in promoting cytoprotective autophagy and mediating DNA damage response under non-lethal stress in human breast cancer cells. The findings suggest new therapeutic avenues by linking effector caspase activity to stress adaptation and genomic stability.

• Dorsomorphin (Compound C): Precision Tools for Metabolic and

  2026-04-24

  Explore the advanced use of Dorsomorphin (Compound C) as a selective AMPK and BMP pathway inhibitor. This article uniquely focuses on practical assay optimization, protocol decisions, and real-world differentiation for researchers working with metabolic and autophagic pathways.

• Neurotensin: Advancing GPCR Trafficking & miRNA Research

  2026-04-24

  This thought-leadership article bridges cutting-edge mechanistic insights into Neurotensin’s role as a Neurotensin receptor 1 activator with actionable strategies for translational researchers. We examine how careful experimental design—leveraging precision reagents like APExBIO Neurotensin (CAS 39379-15-2)—enables robust GPCR trafficking mechanism studies and miRNA regulation in gastrointestinal cells, overcoming key analytical challenges such as spectral interference. By synthesizing recent advances in fluorescence-based detection and miRNA signaling, we chart a vision for interference-free, high-fidelity translational workflows that directly address unmet needs in gastrointestinal and neurobiological research.

• Leucovorin Calcium: Advancing Translational Assembloid Oncol

  2026-04-23

  This thought-leadership article explores the mechanistic and strategic dimensions of Leucovorin Calcium (calcium folinate) in contemporary translational oncology, spotlighting its role in overcoming methotrexate-induced growth suppression and advancing complex assembloid model research. By integrating recent evidence from patient-derived gastric cancer assembloid studies, the article provides actionable guidance for translational scientists aiming to optimize cell viability, decode drug resistance, and accelerate the development of personalized cancer therapies.

• Tacalcitol Monohydrate: Synthetic Vitamin D3 in Applied Rese

  2026-04-23

  Tacalcitol monohydrate, a synthetic analog of vitamin D3, bridges advanced dermatology and oncology workflows with robust NGF induction and synergistic anticancer effects. Discover stepwise experimental setups, troubleshooting, and actionable protocol parameters for maximizing data quality and reproducibility with this low-toxicity vitamin D analog.

• VDR Activation Inhibits Ferroptosis in Cisplatin-Induced AKI

  2026-04-22

  This study demonstrates that activating the vitamin D receptor (VDR) mitigates cisplatin-induced acute kidney injury (AKI) by suppressing ferroptosis, a regulated, iron-dependent cell death pathway. The findings reveal a mechanistic link between VDR signaling, the antioxidant enzyme GPX4, and the inhibition of ferroptosis, offering new insights for therapeutic strategies in AKI.

• Budesonide in Pulmonary Drug Permeability: Scientific Advanc

  2026-04-22

  Explore how Budesonide, a leading anti-inflammatory corticosteroid, enables next-generation pulmonary drug permeability assays. This article uniquely connects biomimetic chromatography insights with practical guidance for respiratory inflammation research.

• Novel Culture Paradigm Extends Mouse Corneal Epithelial Prol

  2026-04-21

  An X et al. present a feeder-free, serum-free 6C medium containing small-molecule modulators—including IWP-2—enabling prolonged proliferation and maintenance of mouse corneal epithelial cells (mCEC) in vitro and in vivo. This approach advances corneal regenerative research by suppressing epithelial-mesenchymal transdifferentiation and improving the harvest of progenitor cells for transplantation applications.

• MCC950 Sodium in Endothelial Pyroptosis: Precision Tools for

  2026-04-21

  Explore the advanced application of MCC950 sodium in dissecting pyroptosis and vascular inflammation, with a focus on endothelial cell dysfunction in atherosclerosis. This article uniquely integrates mechanistic insights, protocol guidance, and translational value for inflammatory disease research.

• Methotrexate: Folate Antagonist Mechanisms & Research Protoc

  2026-04-20

  Methotrexate is a folate antagonist that inhibits dihydrofolate reductase (DHFR), blocking DNA synthesis and cell proliferation. It is widely used as an immunosuppressive and anti-inflammatory agent in research. Robust evidence supports its utility in apoptosis induction and permeability profiling.

• Actin–Myosin II Network Regulates DEV Proliferation via VP26

  2026-04-20

  This study identifies host actin–myosin II cytoskeletal proteins as critical interactors of the duck enteritis virus (DEV) protein VP26, revealing that disruption of this network reduces viral proliferation. The findings offer mechanistic insight into DEV-host interactions and highlight actin polymerization inhibitors like Latrunculin A as useful tools for dissecting cytoskeletal roles in viral infection.

• Ceruletide in Pancreatic Function Research: Protocols & Insi

  2026-04-19

  Ceruletide enables robust, reproducible modeling of pancreatic fibrosis and gastrointestinal motility—critical for translational digestive disease research. This guide bridges recent advances in MFGE8-targeted fibrosis pathways with practical workflows, protocol enhancements, and troubleshooting tips, all leveraging APExBIO’s high-purity synthetic decapeptide.

• LGK-974: Precision PORCN Inhibitor for Wnt Pathway Research

  2026-04-18

  LGK-974 enables precise, low-cytotoxicity modulation of the Wnt/β-catenin pathway—advancing studies in pancreatic cancer, RNF43-mutant models, and β-catenin-driven tumor regression. This guide translates cutting-edge evidence and real-world troubleshooting into actionable protocols for superior reproducibility and translational insight.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Insig

  2026-04-17

  The referenced study establishes moesin (MSN) as a novel biomarker that reflects the severity of endothelial injury in sepsis, correlating with established clinical indices and experimental markers of vascular damage. This finding opens avenues for more precise assessment and mechanistic study of endothelial dysfunction in sepsis, with implications for translational research on vascular permeability and inflammation.

• Scenario-Driven Best Practices Using GSK2606414 (SKU A3448)

  2026-04-16

  This article delivers evidence-based guidance for deploying GSK2606414 (SKU A3448) as a selective PERK inhibitor in ER stress research. Through five scenario-based Q&A blocks, it addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how GSK2606414 ensures reliability and reproducibility. Practical workflow recommendations and quantitative literature data are integrated for translational researchers.

15642 records 1/1043 page Next 12345 下5页 Last page